Literature DB >> 18254124

Abstinence-plus programs for HIV infection prevention in high-income countries.

K Underhill, P Montgomery, D Operario.   

Abstract

BACKGROUND: Abstinence-plus interventions promote sexual abstinence as the best means of preventing acquisition of HIV, but also encourage safer-sex strategies (eg condom use) for sexually active participants.
OBJECTIVES: To assess the effects of abstinence-plus programs for HIV prevention in high-income countries. SEARCH STRATEGY: We searched 30 electronic databases (eg CENTRAL, PubMed, EMBASE, AIDSLINE, PsycINFO) ending February 2007. Cross-referencing, hand-searching, and contacting experts yielded additional citations. SELECTION CRITERIA: We included randomized and quasi-randomized controlled trials evaluating abstinence-plus interventions in high-income countries (as defined by the World Bank). Interventions were any efforts that encouraged sexual abstinence as the best means of HIV prevention, but also promoted safer sex. Results were self-reported biological outcomes, behavioral outcomes, and HIV knowledge. DATA COLLECTION AND ANALYSIS: Three reviewers independently appraised 20070 citations and 325 full-text papers for inclusion and methodological quality; 39 evaluations were included. Due to heterogeneity and data unavailability, we presented the results of individual studies instead of a meta-analysis. MAIN
RESULTS: Studies enrolled 37724 North American youth; participants were ethnically diverse. Programs took place in schools (10), community facilities (24), both schools and community facilities (2), healthcare facilities (2), and family homes (1). Median final follow-up occurred 12 months after baseline. Results showed no evidence that abstinence-plus programs can affect self-reported sexually transmitted infection (STI) incidence, and limited evidence that programs can reduce self-reported pregnancy incidence. Results for behavioral outcomes were promising; 23 of 39 evaluations found a significantly protective intervention effect for at least one behavioral outcome. Consistently favorable program effects were found for HIV knowledge.No adverse effects were observed. Several evaluations found that one version of an abstinence-plus program was more effective than another, suggesting that more research into intervention mechanisms is warranted. Methodological strengths included large samples and statistical controls for baseline values. Weaknesses included under-utilization of relevant outcomes, self-report bias, and analyses neglecting attrition and clustered randomization. AUTHORS'
CONCLUSIONS: Many abstinence-plus programs appear to reduce short-term and long-term HIV risk behavior among youth in high-income countries. Evidence for program effects on biological measures is limited. Evaluations consistently show no adverse program effects for any outcomes, including the incidence and frequency of sexual activity. Trials comparing abstinence-only, abstinence-plus, and safer-sex interventions are needed.

Entities:  

Mesh:

Year:  2008        PMID: 18254124     DOI: 10.1002/14651858.CD007006

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  15 in total

Review 1.  Interventions for encouraging sexual behaviours intended to prevent cervical cancer.

Authors:  Jonathan P Shepherd; Geoff K Frampton; Petra Harris
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 2.  Systematic review of interventions to prevent the spread of sexually transmitted infections, including HIV, among young people in Europe.

Authors:  Jeffrey V Lazarus; Henna Sihvonen-Riemenschneider; Ulrich Laukamm-Josten; Fiona Wong; Jerker Liljestrand
Journal:  Croat Med J       Date:  2010-02       Impact factor: 1.351

3.  Do School-Based Programs Prevent HIV and Other Sexually Transmitted Infections in Adolescents? A Systematic Review and Meta-analysis.

Authors:  Ali Mirzazadeh; M Antonia Biggs; Amanda Viitanen; Hacsi Horvath; Li Yan Wang; Richard Dunville; Lisa C Barrios; James G Kahn; Elliot Marseille
Journal:  Prev Sci       Date:  2018-05

4.  Effectiveness of School-Based Teen Pregnancy Prevention Programs in the USA: a Systematic Review and Meta-Analysis.

Authors:  Elliot Marseille; Ali Mirzazadeh; M Antonia Biggs; Amanda P Miller; Hacsi Horvath; Marguerita Lightfoot; Mohsen Malekinejad; James G Kahn
Journal:  Prev Sci       Date:  2018-05

5.  Abstinence and teenagers: prevention counseling practices of health care providers serving high-risk patients in the United States.

Authors:  Cynthia C Harper; Jillian T Henderson; Amy Schalet; Davida Becker; Laura Stratton; Tina R Raine
Journal:  Perspect Sex Reprod Health       Date:  2010-06

6.  Randomized controlled trial on the effectiveness of counseling messages for avoiding unprotected sexual intercourse during sexually transmitted infection and reproductive tract infection treatment among female sexually transmitted infection clinic patients.

Authors:  Clive Anderson; Maria F Gallo; Tina Hylton-Kong; Markus J Steiner; Marcia M Hobbs; Maurizio Macaluso; J Peter Figueroa; Denise J Jamieson; Jennifer Legardy-Williams; Jeffrey Wiener; Lee Warner
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

Review 7.  Contraception for HIV-Infected Adolescents.

Authors:  Athena P Kourtis; Ayesha Mirza
Journal:  Pediatrics       Date:  2016-09       Impact factor: 7.124

Review 8.  Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.

Authors:  Juntana Pattanaphesaj; Yot Teerawattananon
Journal:  BMC Public Health       Date:  2010-07-07       Impact factor: 3.295

9.  HIV-prevention science at a crossroads: advances in reducing sexual risk.

Authors:  Sten H Vermund; Katherine L Allen; Quarraisha Abdool Karim
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

10.  Recommendations for increasing the use of HIV/AIDS resource allocation models.

Authors:  Arielle Lasry; Anke Richter; Frithjof Lutscher
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.